We only have this paper's title and publication details.
Read it at the sourceMulticentre case series reports maternal and neonatal outcomes in pregnancies exposed to interleukin-17 inhibitors, highlighting safety considerations during biologic therapy.
No takes yet. Share an insight, caveat, or question.
Waring et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: